Clinical Trial Update: New Horizons in the Treatment of Vitreous Floaters [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study for treating vitreous opacities, commonly called vitreous floaters; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitreous Floaters
• Vitreous Opacities

Snippet

Sponsor: Augenabteilung Allgemeines Krankenhaus Linz | Conditions: Other Vitreous Opacities, Bilateral | Phase 4 | Status: UNKNOWN